Simtra BioPharma Solutions Launches First Sustainability Report
Simtra BioPharma Solutions, a prominent company in the contract development and manufacturing industry, has recently unveiled its first Sustainability Report. This comprehensive document outlines the company's achievements and aspirations related to environmental responsibilities and sustainable practices.
Commitment to Sustainability
The report showcases how, since becoming independent, Simtra BioPharma Solutions has prioritized environmental, social, and governance (ESG) matters. CEO Franco Negron emphasizes that these elements are crucial for shaping the company's operations and positively impacting its employees, customers, and the communities it serves.
Key Achievements in Sustainability
Some significant highlights from the Sustainability Report include:
Environmental Initiatives
The company conducted its first greenhouse gas (GHG) emissions inventory, setting waste reduction goals in line with international standards such as ISO 14001 and ISO 50001. Simtra's commitment to using modern equipment aids in maintaining sustainable and efficient manufacturing processes.
Waste Management and Carbon Offset
One of the remarkable achievements is the recycling of 51% of its waste across various manufacturing sites. Additionally, the company successfully offset approximately 1,400 tons of CO2 emissions through the installation of solar panels at one of its facilities.
Employee Development
Simtra BioPharma Solutions has also expanded its workforce by 26% and updated its onboarding and training programs. This growth reflects the company's dedication to cultivating a skilled and motivated workforce.
Supplier Sustainability
More than 430 supplier diligence checks were completed, and the company has achieved EcoVadis ratings, demonstrating its commitment to responsible sourcing and supply chain management.
Formation of a Sustainability Committee
To ensure ongoing progress, a dedicated Sustainability Committee has been established. This committee will oversee initiatives and hold the organization accountable for its sustainability goals.
A Vision for the Future
General Counsel and Chief Compliance Officer, James Garrett, describes the release of the report as a starting point, stating that it illustrates Simtra's current standing and provides a roadmap for future accountability and growth. The organization's aim is clear: to become the leading CDMO for sterile injectable products while maintaining high sustainability standards.
About Simtra BioPharma Solutions
As a leading Contract Development Manufacturing Organization, Simtra BioPharma Solutions boasts over 65 years of expertise in sterile injectable manufacturing. With a focus on cGMP sterile fill and finish services, the company combines technical know-how with exceptional quality service. Their collaborative approach ensures that customer strategic objectives are met effectively.
Frequently Asked Questions
What is the purpose of Simtra's Sustainability Report?
The report serves to communicate Simtra's commitment to sustainability goals and highlights their successes in environmental initiatives.
What are the key highlights in the 2024 report?
Key highlights include waste reduction goals, recycling achievements, employee growth, supplier diligence checks, and the establishment of a Sustainability Committee.
How has Simtra BioPharma Solutions impacted the environment?
Simtra has recycled significant waste and offset a substantial amount of CO2 emissions through renewable energy installations.
How does Simtra support its employees?
The company has revamped its onboarding and training programs while expanding its workforce to enhance employee development.
What future goals does Simtra have regarding sustainability?
Simtra aims to build a leading CDMO while continuing to uphold high sustainability standards and accountability measures.
